Kidney Disease Archives - Clinical Advisor

Pregnancy Found to Increase Risk of First-Time Symptomatic Kidney Stones

By

Jody A. Charnow

May 7, 2021

The risk for a first-time symptomatic kidney stone begins to increase in the second trimester and peaks 0 to 3 months after delivery, a study findings suggest.

Nephrology Information Center

Zinc Deficiency May Up Infection-Related Hospitalizations in Advanced CKD

By

Natasha Persaud

March 16, 2021

Nearly 80% of patients in a recent study had very low serum zinc values, which raises concern for the advanced CKD population at large, according to investigators.

Nephrology Information Center

Waitlist Placement, Kidney Transplant Rates Not Improving

February 18, 2021

For patients with end-stage kidney disease, there has been little improvement in rates of waitlist placement or transplantation since 1997.

Diabetes Information Center

NSAIDs May Increase AKI, Hyperkalemia Risks in Diabetes

By

Natasha Persaud

January 20, 2021

Study findings suggest NSAIDs may be a risk factor for acute kidney injury and hyperkalemia in patients with diabetes.

Hematology Information Center

Hematopoietic Stem Cell Transplantation May Not Reduce Renal Function in Sickle Cell Disease

By

Lauren Dembeck, PhD

December 29, 2020

For patients with sickle cell disease, HSCT may not be associated with a significant increase in CKD incidence or prevalence following transplantation.

Nephrology Information Center

Canagliflozin Beneficial Even for Advanced Kidney Disease

December 4, 2020

Treatment with the sodium glucose cotransporter 2 (SGLT2) inhibitor canagliflozin can reduce rates of kidney disease progression.

Nephrology Information Center

Opioids More Harmful Than NSAIDs in Chronic Kidney Disease

By

Jody A. Charnow

April 30, 2020

Compared with nonsteroidal anti-inflammatory drugs, opioids are more likely to result in adverse kidney outcomes and death, a study found.

Infectious Diseases Information Center

Joint Statement Issued Addressing Concerns Over COVID-19 and ACE Inhibitor, ARB Use

By

Cassandra Pardini, PharmD

March 20, 2020

Patients with cardiovascular disease diagnosed with novel coronavirus (COVID-19) are urged to continue taking their angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) medications as prescribed.